Last updated on May 24th, 2025 at 10:15 pm
UGC NET Ayurveda Biology coaching
- Course Validity: 12 months
- Resources: LMS and Digital Library Access – Pre-recorded videos , Digital Notes, Printed book set (optional paid add on), MCQs & Mock Tests
- Content: Covers entire UGC NET Ayurveda Biology syllabus
- Language: Lectures – majorly in Hindi, Reading materials & test series in English
UGC NET Ayurveda Biology Coaching – Key Highlights
- Mode: 100% Online
- Study Materials: Comprehensive digital notes, pre-recorded videos, MCQs for practice, mock tests, printed book (optional paid add on).
- Syllabus: Covers all 10 units recommended by UGC NET
- Expert Faculty: Experienced professionals specializing in Ayurveda and biology.
- Flexible Learning: Self-paced study with recorded lectures and accessible resources.
- Designed for Beginners & Experts: Tailored content for all levels of aspirants.
Limited Seats, have you booked your’s?
Q91. What is the Kalka: Sneha: Drava ratio in Sneha Kalpana?
Option A. 1:4:16
Option B. 1:2:4
Option C. 1:8:32
Option D. 1:2:3
Correct Ans – Option C (1:8:32)
Explanation –
Classically in Sneha Kalpana, Kalka:Sneha:Drava = 1:8:32 is standard for decoction-based sneha formulations.
Q92. Match Prakriti features with modern phenotyping methods:
Prakriti Feature | Modern Phenotyping Method |
A. Aakriti | III. Phototypes |
B. Varna | II. Somatotypes |
C. Nidra | I. Chronotypes |
D. Agni-koshtha | IV. Metabotypes |
Correct Ans – Option 1 (A-III, B-II, C-I, D-IV)
Explanation –
- Aakriti → external build → Phototype
- Varna → body composition → Somatotype
- Nidra → sleep pattern → Chronotype
- Agni → digestion → Metabotype
Q93. The Indian Patents Act was introduced in the year:
Option A. 1970
Option B. 1955
Option C. 1984
Option D. 2012
Correct Ans – Option A (1970)
Explanation –
The Indian Patents Act came into effect in 1970, replacing the British-era Indian Patents and Designs Act of 1911.
Q94. Arrange WBCs by increasing count in normal human blood:
A. Neutrophils
B. Basophils
C. Lymphocytes
D. Monocytes
E. Eosinophils
Correct Ans – Option 3 (A, C, D, B, E)
Explanation –
Common count order (from highest to lowest):
Neutrophils > Lymphocytes > Monocytes > Eosinophils > Basophils
But increasing order is the reverse:
Basophils < Eosinophils < Monocytes < Lymphocytes < Neutrophils
So, correct increasing order: B, E, D, C, A
→ Note: Option 3 might have a mismatch unless B and E are correctly placed
Q95. Which of the following bonds is NOT part of polynucleotide sequence?
Option A. Hydrogen bond
Option B. Phosphodiester bond
Option C. Amide bond
Option D. Glycosidic bond
Correct Ans – Option C (Amide bond)
Explanation –
Polynucleotides:
- Phosphodiester bonds between sugar-phosphate backbone
- Hydrogen bonds between nitrogenous bases
- Glycosidic bond between sugar and base
- Amide bonds occur in proteins, not DNA/RNA
Q96. Correct sequence in Avaleha preparation:
A. Preparation of Kwatha
B. Reduction of mixture
C. Addition of sweetening agent
D. Addition of Prakshepa Dravya
E. Addition of honey
Correct Ans – Option 2 (A, C, D, B, E)
Explanation –
- Prepare Kwatha
- Add sugar/jaggery (sweetener)
- Add Prakshepa Dravya
- Reduce to thick paste
- Add honey (after cooling)
Q97. Match List-I (Dhatu) with List-II (Function):
Dhatu | Function |
A. Rakta | III. Preenana |
B. Rasa | IV. Jeevana |
C. Asthi | II. Dhaarana |
D. Meda | I. Snehana |
Correct Ans – Option 3 (A-IV, B-III, C-II, D-I)
Explanation –
- Rakta → Jeevana (life)
- Rasa → Preenana (nourishment)
- Asthi → Dhaarana (support)
- Meda → Snehana (lubrication)
Q98. Appropriate sequence for use of Rasa in Ahara (diet):
A. Madhura
B. Amla, Lavana
C. Katu
D. Tikta
E. Kashaya
Correct Ans – Option 3 (A, B, C, D, E)
Explanation –
The Ayurvedic Ahara Vidhi recommends this order of rasas:
Madhura → Amla → Lavana → Katu → Tikta → Kashaya
Q99. In biotech startups, what does “Scaling up” refer to?
Option A. Increasing company size
Option B. Expanding new markets
Option C. Increasing the production
Option D. Raising more funds
Correct Ans – Option C (Increasing the production)
Explanation –
“Scaling up” in biotech usually refers to moving from lab-scale to mass production, particularly in drug or compound manufacturing.
Q100. The receptor for HIV on target cells is:
Option A. CD1
Option B. CD3
Option C. CD4
Option D. CD8
Correct Ans – Option C (CD4)
Explanation –
HIV primarily infects CD4+ T-helper cells via the CD4 receptor, leading to immune system suppression.